logo
Sign in

ARGX Stock Price, Chart, Stats & News

56.14B
Market cap
40.37x
Current P/E
32.89x
Forward P/E

ARGX chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
79.70%
Operating margin
20.32%
Pretax margin
26.43%
Net margin
39.25%
Effective tax rate
-48.30%
ROA
24.82%
ROE
34.18%
D/E
0.01x
Interest coverage ratio
233.37x

ARGX valuation

P/E
40.37x
P/S
7.79x
P/B
5.80x
P/CF
47.84x
P/FCF
48.60x
P/OCF
47.84x
PEG
0.20x
EV multiple
28.28x

About

argenx SE, a biotechnology company established in Amsterdam, the Netherlands, in 2008, is dedicated to developing innovative therapies primarily for autoimmune diseases. The company's operations span across key global markets, including the United States, Japan, Europe, the Middle East, Africa, and China. Its leading investigational therapy is efgartigimod, which is being developed to address a broad range of conditions.

Similar securities

Based on sector and market capitalization

Report issue